Investor Relations

SPOTLIGHT

Thumbnailwb-_RCT_Trial_Results.png

Perimeter's Claire is an adjunctive OCT and AI screening tool designed to assist surgeons in breast cancer margin assessment. In its successful Pivotal Trial, Claire met its primary endpoint in a within-subject analysis, demonstrating the ability to significantly reduce diseased margins when used adjunctively as a collaborative human-AI team.

Company Overview

About Perimeter Medical Imaging AI, Inc.

Based in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI (TSX-V:PINK) (OTC:PYNKF) (FSE:4PC) is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the U.S., our FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The breakthrough-device-designated investigational Perimeter B-Series OCT with ImgAssist AI represents our next-generation, artificial intelligence technology that is currently under clinical development. The company’s ticker symbol “PINK” is a reference to the pink ribbons used during Breast Cancer Awareness Month.

Investor Contact Information

Company

Perimeter Medical Imaging
555 Richmond St W
Suite 511
Toronto, ON M5V 3B1
Toll-Free: (888) 988-7465 (PINK)
T: (214) 845-5154
F: (972) 587-7795
investors@perimetermed.com

Transfer Agent

Computershare
P.O. Box 43078
Providence, RI 02940
https://www.computershare.com

Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.